Baptist Health South Florida and biotech company RESTEM announced this week that three COVID-19 patients with acute respiratory distress syndrome are the first to successfully be treated in the U.S. with umbilical cord mesenchymal stem cells under an emergency approval from the FDA.
Trending:
Baptist Health South Florida physicians successfully treat first three COVID-19 critically ill patients with RESTEM’s umbilical cord mesenchymal stem cells